Health Condition 1: I20-I25- Ischemic heart diseases
Conditions
Interventions
Intervention1: NIL: NIL
Sponsors
CARDIOVASCULAR RESEARCH SOCIETY
Eligibility
Inclusion criteria
Inclusion criteria: Patients who are more than 18 years undergoing PCI to native vessel with DCB and Vessels with reference diameter 2.0 â?? 4mm
Exclusion criteria
Exclusion criteria: Saphenous vein graft & other bypass graft lesions Left main Severe tourtous lesions Heavily calcified lesions Vessel diameter morethan 4.0mm Expected life expectancy less than 1 year Severe liver disease lessthan Child Pugh B Severe CKD eGFR morethan 30ml/min/m2 Advanced malignancy Known contraindication for paclitaxel or sirolimus
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| To study clinical procedural characteristics of patients undergoing PCI with DCB in native vessel disease Lesion sub sets like large vessel morethan 3.0mmTimepoint: In hospital 30 days 3 days 6 days 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Long lesions-bifurcations-Chronic total occlusions CTO, proximal vessel disease receiving DCB treatment are of special interest-Clinical subsets like ST elevation myocardial infarction STEMI- non ST elevation acute coronary syndromes NSTEACS are to be studiedTimepoint: In hospital 30 days 3 days 6 days 12 months | — |
Countries
India
Contacts
Public ContactDR JABIR ABDULLAKUTTY
Outcome results
None listed